Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5594375 | American Heart Journal | 2017 | 8 Pages |
Abstract
IDEAL-LM is designed to assess the safety and efficacy of the novel Synergy stent followed by 4 months of DAPT vs the Xience stent followed by 12 months of DAPT in patients undergoing uLMCA PCI. The study will provide novel insights regarding optimal treatment strategy for patients undergoing PCI of uLMCA disease (www.clinicaltrials.gov, NCT 02303717).
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Miguel E. MD, PhD, Keith MB, ChB, MD, Paul MD, Maciej MD, Robert A. MB, BCh, PhD, Evgeny MD, Joost MD, PhD, Yoshinobu MD, PhD, Karen CCRN, Robert-Jan MD, PhD,